The terminal proteins TP1 and TP2 are putative products of Epstein-Barr virus (EBV) genes expressed during the latent cycle of the virus. They are predicted to code for 53-and 40-kilodalton integral membrane proteins. We used the baculovirus Autographa californica nuclear polyhedrosis virus as an expression vector to produce TP1 in large amounts in insect cells. The DNA sequences used to express TP1 originated from a TP1 cDNA derived from an M-ABA/CBL1 cDNA library. Rabbit antisera raised against procaryotic TP1 fusion proteins recognized a monomer and a dimer of the recombinant TP1 protein in the infected insect cells. Immunofluorescence studies of living insect cells showed that the recombinant protein is located in the plasma membrane. The insect cells infected with the recombinant baculovirus producing TP1 provided a test system to screen human antisera for TP1 antibodies. A total of 168 human EBV-positive and EBV-negative antisera were studied. TP1 antibodies were detected only in sera from nasopharyngeal carcinoma patients (16 out of 42). Rabbit antiserum raised against the recombinant TP1 protein expressed in the baculovirus system specifically recognized a protein of about 54 kilodaltons in the lymphoblastoid cell lines M-ABA and M-ABA/CBL1 and in the Burkitt's lymphoma cell lines BL18 and BL72. This protein could be located in the total membrane fraction of M-ABA cells and is upregulated by treating the cells with 12-O-tetradecanoylphorbol-13-acetate.
The terminal proteins TP1 and TP2 are putative products of Epstein-Barr virus (EBV) genes expressed during the latent cycle of the virus. They are predicted to code for 53-and 40-kilodalton integral membrane proteins. We used the baculovirus Autographa californica nuclear polyhedrosis virus as an expression vector to produce TP1 in large amounts in insect cells. The DNA sequences used to express TP1 originated from a TP1 cDNA derived from an M-ABA/CBL1 cDNA library. Rabbit antisera raised against procaryotic TP1 fusion proteins recognized a monomer and a dimer of the recombinant TP1 protein in the infected insect cells. Immunofluorescence studies of living insect cells showed that the recombinant protein is located in the plasma membrane. The insect cells infected with the recombinant baculovirus producing TP1 provided a test system to screen human antisera for TP1 antibodies. A total of 168 human EBV-positive and EBV-negative antisera were studied. TP1 antibodies were detected only in sera from nasopharyngeal carcinoma patients (16 out of 42). Rabbit antiserum raised against the recombinant TP1 protein expressed in the baculovirus system specifically recognized a protein of about 54 kilodaltons in the lymphoblastoid cell lines M-ABA and M-ABA/CBL1 and in the Burkitt's lymphoma cell lines BL18 and BL72. This protein could be located in the total membrane fraction of M-ABA cells and is upregulated by treating the cells with 12-O-tetradecanoylphorbol-13-acetate.
Epstein-Barr virus (EBV)
, an ubiquitous human herpesvirus, is the etiological agent of infectious mononucleosis. It is closely associated with two human tumors, nasopharyngeal carcinoma (NPC) and Burkitt's lymphoma (BL) (7) . EBV infects and immortalizes B lymphocytes in vitro (11) .
The linear viral genome is organized as two regions of unique sequences, Us (short) and UL (long), separated by an array of internal 3.1-kilobase (kb) repeats and flanked by direct terminal repeats (2) . After infection, the EBV genome normally circularizes at its terminal repeats and the viral DNA is maintained as multiple copies of episomal molecules in the immortalized cells (19) . Evidence for integration of viral copies into the cellular genome has also been provided for some cell lines (10, 22) . EBV-immortalized cells are latently infected by the virus since the lytic cycle of EBV is suppressed and only a subset of viral genes is expressed in the cells. These are the genes coding for the nuclear antigens (6, 8, 24, 26, 30, 32) , the latent membrane protein (12) , and the terminal proteins (14, 17, 27) . The products of the genes expressed in latently infected cells are of particular interest because they are believed to be essential for the growth transformation of B lymphocytes by EBV and the maintenance of the latent state of the virus. It is a unique feature of the terminal genes that their transcripts cross the terminal repeats and that the coding sequences of the genes are created only by circularization or multimerization of the linear viral genome. Two poly(A)+ RNAs, 1.7 and 2.0 kb in length, have been described as being constitutively expressed from the short unique region of B95-8 virus (14) . They are present in a wide variety of EBV-infected B-cell lines, including nonproducer cell lines. Analysis of two cDNAs showed that both transcripts consist of nine exons (17, 27) . They share the eight C-terminal exons located in the short unique region of EBV and differ only in the N-terminal first exon located in the long unique region close to the right-hand end of the linear genome (17, 27) .
The putative translation products of the 2.0-and 1.7-kb RNAs are designated terminal protein 1 (TP1) and terminal protein 2 (TP2), respectively (17; G. Laux and P. J. Farrell, personal communication). According to its amino acid sequence, TP1 is a mainly hydrophobic protein with a hydrophilic amino terminus and a molecular mass of about 53 kilodaltons (kDa). TP2 lacks the hydrophilic amino terminus and has a molecular mass of about 40 kDa. Both proteins are predicted to be integral membrane proteins with 12 transmembrane domains.
In vitro translation experiments showed that the 2.0-and 1.7-kb transcripts are translated into a 54-and 40-kDa protein, respectively (27) . Both in vitro-synthesized proteins could be shown to be membrane associated. However, neither of the proteins could so far be found in latently infected B cells, nor could antibodies be detected in human sera which specifically recognized the terminal proteins synthesized in vitro.
We have expressed TP1 in large amounts in the eucaryotic baculovirus expression vector system. Using the recombinant protein as an antigen, we were able to detect antibodies to TP1 in human sera. By expressing TP1 in a procaryotic system and generating TP-specific rabbit antisera we could identify TP1 as a fusion protein of about 56 kDa in insect cells infected with the recombinant baculovirus as well as a protein of about 54 kDa in the EBV-positive B-cell lines M-ABA, M-ABA/CBL1, BL18, and BL72.
MATERIALS AND METHODS
Cell lines and virus. BJAB and BL41 are EBV-negative BL cell lines (15, 18) . BL18, BL72, BL74, Ly9l, and Jijoye are EBV-positive BL cell lines (3, 13, 18) . M-ABA is a marmoset cell line established by cocultivation of marmoset lymphocytes with EBV derived from an NPC, and B95-8 is a marmoset cell line established by cocultivation with EBV derived from a patient with infectious mononucleosis (5, 23 Immunizations. Procaryotic and eucaryotic fusion proteins were purified by electrophoresis in 10% SDS-polyacrylamide gels, and the gels were stained as previously described (37 (20) . In parallel, the same cDNA was digested with BamHI and cloned into a pAC 360 vector cut with BamHI (20) .
Baculovirus plasmid transfer vectors were designed in a way that they contained the polyhedrin-encoding sequences of AcNPV flanked by several kilobases of AcNPV sequences which allow recombination with the wild-type virus in cotransfection experiments. pAC 409 and pAC 360 carry the restriction sites for cloning downstream of the polyhedrin initiation site. Thus, recombination results in the production of fusion proteins with 9 and 12 N-terminal polyhedrin amino acids, respectively. SF158 cells were cotransfected with 1 ,ug of baculovirus genomic DNA and 2 jig of recombinant transfer vector DNA by the calcium phosphate transfection method (34) . At 4 days after transfection, extracellular virions were collected and allowed to form plaques as previously described (34) . The cells were transferred to nitrocellulose filters and lysed by placing the filters in a 5% SDS solution for 10 min. isothiocyanate-conjugated goat anti-rabbit IgG antibodies under the same conditions. After each incubation step, the cells were washed three times in ice-cold PBS.
Immunoblots. SF158 cells and B cells were washed in PBS and then disrupted by sonication either under reducing conditions in a sample buffer containing 6% SDS and 10% mercaptoethanol or (additionally) 8 M urea or in the absence of reducing agents under alkylating conditions in a sample buffer containing 6% SDS and 0.05 M iodoacetate. The proteins were separated on polyacrylamide gels and electrophoretically transferred to Immobilon membranes (Millipore Corp.) as previously described (35) . The blots were incubated with rabbit antisera at a dilution of 1:400 and then stained indirectly either by using peroxidase-conjugated goat anti-rabbit antibodies or by using the peroxidase-antiperoxidase technique.
In competition assays, the antisera used for staining were preincubated on ice with 2 ,ug of isolated fusion protein or anthranilate synthetase protein per ml for 1 h and 30 min.
Total membrane preparation. The total membrane preparation was based on a method previously described (21) . Cells (107) were pelleted, washed in PBS, and suspended in cold lysing buffer (10 mM Tris [pH 7.5], 1 mM KCl, 1 mM MgCl2). The cell suspension was sonicated, and the nuclei were pelleted by centrifugation at 800 x g for 15 min. The nuclear pellets were washed twice. Supernatants from individual washing steps were pooled and centrifuged at 100,000 x g for 1 h to pellet the total membrane fraction. Soluble proteins in the resulting supernatant were precipitated with absolute ethanol at -20°C. The pellets of the three subcellular fractions were suspended by sonication in sample buffer as mentioned above and analyzed by SDS-PAGE and immunoblotting.
RESULTS
Expression of procaryotic TP1 fusion proteins. A procaryotic expression vector encoding part of the first exon of TP1 was obtained by cloning a 2.4-kilobase-pair BamHI-BglII fragment of the genomic M-ABA DNA clone 961-20 in frame with the anthranilate synthetase-coding sequences contained in the pATH1 vector. Of the genomic fragment, 303 base pairs were derived from the first exon of TP1. The 18 N-terminal amino acids of the first exon of TP1 were missing in this fragment. The intron sequence contained a stop codon directly adjacent to the coding sequences so that only TP1 (101 amino acids) sequences were expressed. The observed electrophoretic mobility of the fusion protein was about 50 kDa, which is in the expected range of 48 kDa (data not shown).
Additionally, a BamHI-SmaI fragment of the M-ABA/ CBL1 cDNA ( Fig. 1) was cloned in pATH10. The cDNA fragment contained nearly the complete reading frame of TP1, again lacking the 18 N-terminal amino acids. The resulting fusion protein showed a relative molecular mass of about 90 kDa and a high degree of spontaneous degradation (data not shown).
Expression of TP1 fusion proteins in the baculovirus system. A PstI-SmaI fragment of the M-ABA/CBL1 cDNA which contained the complete coding sequences of TP1 was cloned into the pAC 409 vector, and a BamHI fragment of the same cDNA which lacked the 18 N-terminal amino acids was cloned into the pAC 360 vector as described in Materials and Methods (Fig. 1B) .
SF158 cells were cotransfected with AcNPV DNA and a recombinant transfer vector. Recombination between Ac-NPV sequences present in the transfer vectors and viral DNA resulted in polyhedrin-negative plaques expressing TP1 which were identified by immunocolonyblot analysis as described in Materials and Methods.
SF158 cells infected with the recombinant baculoviruses were examined at 8, 12, 16, 20, 25, 36 , and 48 h postinfection for the expression of TP1 fusion proteins. The cells were fixed in acetone and stained by indirect immunofluorescence with rabbit antisera raised against the two procaryotic fusion proteins. Both antisera exhibited strong reactions with the infected SF158 cells from 20 h postinfection and later ( Fig.  2A) .
The rabbit preimmune sera did not react with the recombinant protein expressed in SF158 cells (data not shown), nor did the immune sera react with cells infected by wildtype AcNPV only (Fig. 2B) (Fig. 2C) . These cells synthesized TP1 in large amounts (Fig. 3A) and could therefore be used for detection of anti-TP antibodies in human sera. The immunofluorescence pattern of TP-positive human sera fit with the pattern obtained with the rabbit antisera ( Fig. 2A (Fig.  4A) . It turned out that a sample buffer containing 8 M urea increased the solubility of the specific protein (data not shown). For a demonstration of the subcellular localization of the specific protein band, BL41 and M-ABA cells were fractionated into nuclear, total membrane, and soluble fractions by using differential centrifugation of lysed cells. The different fractions were suspended in alkylating sample buffer and analyzed by SDS-PAGE and immunoblotting. A strong 54-kDa band and, as in the baculovirus system, a weak band of about 110 kDa could be detected only in the total membrane fraction of the cell line M-ABA (Fig. SA) . The staining of both bands could be specifically inhibited by preincubation of the serum with the procaryotic 90-kDa TP1 fusion protein (Fig. SB) . By fractionating other B-cell lines, TP1 could also be detected in the total membrane fractions of the two cell lines, BL18 and BL72 (Fig. 4B) . Furthermore, it could be demonstrated that the terminal protein is upregulated to certain amounts by treating M-ABA cells with TPA after subcultivation (Fig. 6) . The results in Fig. 6 indicate with a TP1-positive human antiserum (C). Antisera were used at dilutions of 1:40. that a maximum of induction of both the dimer and the monomer could be achieved between 12 and 24 h after the addition of TPA.
DISCUSSION
The terminal proteins of EBV cannot easily be detected in EBV-positive cell lines. This may, at least in part, be due to the low abundance of the transcripts of the terminal genes. The overexpression of proteins in eucaryotic expression systems by genetic engineering provides a tool to study the properties and perhaps the function of proteins which are expressed in low amounts in vivo. We chose the baculovirus expression vector system because several mammalian proteins expressed in that system show posttranslational modifications as observed for the same proteins in vivo (16, 29) . Two TP1 fusion proteins, one containing the complete reading frame of TP1 and one lacking 18 N-terminal amino acids, were expressed in the insect cells in high quantities. Analysis of the recombinant protein under reducing conditions on SDS-PAGE resulted in the formation of aggregates which stuck to the tops of the polyacrylamide gels. This problem could be partly overcome by preparation of the cellular extracts in alkylating sample buffer in the absence of reducing agents. The low solubilization of the protein in SDS sample buffer under reducing conditions probably is a matter of the extreme hydrophobicity of the proteins and has already been observed with other membrane proteins (9) . Under alkylating conditions, a TP1 fusion protein of about 56 kDa and a dimer of that protein of about 110 kDa could be detected by immunoblot analysis. We could demonstrate that the high-molecular-weight aggregates and the dimer consist of the 56-kDa fusion protein and are not due to an aggregation with other protein species, since excision of the 56-kDa band and its subsequent resuspension in alkylating sample buffer, analysis in SDS-PAGE, and immunoblotting resulted to a small percentage in the formation of highmolecular-weight aggregates and dimerization of the protein. (27) . Since the surfaces of living insect cells could be stained by indirect immunofluorescence, we suggest that the recombinant protein is located in the plasma membrane. The cells could be stained with a serum directed against the hydrophilic amino terminus, which is predicted not to be located in the membrane. As intact cells are usually impermeable for antibodies, this result at least suggests the possibility that the amino terminus is exposed on the outer surface of the plasma membrane. Yet it cannot be excluded that the inner surfaces of plasma membranes of baculovirusinfected cells are accessible for antibodies. As for the latent membrane protein of EBV, the structure of TP1 derived from the amino acid sequence and the plasma membrane localization of the protein is suggestive of an ion channel or a cellular receptor (1, 33) . TP1 was expressed in high quantities in the insect cells, providing a test system to screen human antisera for antibodies to TP1 by indirect immunofluorescence of infected insect cells. TP1-positive human sera exhibited a specific fluorescence pattern very similar to the pattern obtained with the rabbit antisera. The detection of TP1-positive human antisera is the first proof that TP1 is expressed during the life cycle of EBV in vivo. All TP1-positive antisera were sera from NPC patients. Since NPC sera exhibited very high antibody titers against EBV proteins, control sera were especially selected for high titers against EBV antigens to make sure that the positive immunofluorescence was not merely the effect of high antibody titers against viral proteins. The results indicate that approximately 40% of the NPC patients possessed antibodies against TP1. In further studies, it will be interesting to analyze whether antibody titers develop at a precancerous state or during tumor progression. A more detailed follow-up of NPC patients might reveal whether TP1 is expressed at certain stages of tumor development and thus may serve as a marker for NPC or the prognosis of the tumor. Furthermore, it might be interesting to look for TP1 expression in NPC tumor biopsies in order to clarify the role of TP1 in tumor development.
Finally, we could detect a 54-kDa protein band in total cellular extracts of the lymphoblastoid cell lines M-ABA and M-ABA/CBL1 and in total membrane fractions of the BL cell lines BL18 and BL72, which specifically reacted with a TP1-positive rabbit antiserum. As 
